MB, Levis & Associates’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56K Sell
195
-15
-7% -$264 ﹤0.01% 202
2025
Q4
$5.58K Hold
210
﹤0.01% 180
2025
Q3
$6.31K Hold
210
﹤0.01% 175
2025
Q2
$8.81K Hold
210
﹤0.01% 197
2025
Q1
$6.59K Hold
210
﹤0.01% 205
2024
Q4
$7.27K Hold
210
﹤0.01% 204
2024
Q3
$4.83K Hold
210
﹤0.01% 224
2024
Q2
$5.53K Hold
210
﹤0.01% 216
2024
Q1
$4.57K Hold
210
﹤0.01% 222
2023
Q4
$4.36K Hold
210
﹤0.01% 219
2023
Q3
$3.17K Hold
210
﹤0.01% 230
2023
Q2
$2.79K Sell
210
-20
-9% -$271 ﹤0.01% 236
2023
Q1
$3.4K Sell
230
-440
-66% -$6.24K ﹤0.01% 232
2022
Q4
$7.45K Buy
+670
New +$6.74K 0.01% 196

Other funds holding KD

MB, Levis & Associates's KD Position: Q1 2026 in Review

MB, Levis & Associates reduced its Kyndryl (KD) stake by 7.1% in Q1 2026, selling an estimated $264 and leaving 195 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #202.

MB, Levis & Associates first reported a position in KD in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.81K in Q2 2025. 660 funds tracked by Wall St. Rank hold KD as of Q1 2026.

  • MB, Levis & Associates held 195 shares of Kyndryl worth $2.56K as of Q1 2026.
  • MB, Levis & Associates sold 15 Kyndryl shares in Q1 2026, an estimated $264.
  • Kyndryl made up ﹤0.01% of MB, Levis & Associates's portfolio in Q1 2026, its #202 holding.
  • MB, Levis & Associates first reported a position in Kyndryl in Q4 2022 and has held it in 14 quarters since.
  • MB, Levis & Associates's Kyndryl position peaked at $8.81K in Q2 2025.
  • 660 funds tracked by Wall St. Rank held Kyndryl as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.